Tatva Chintan Pharma IPO is going to hit the market on 16 July 2021 and closes on 20 July 2021. The company to raise ₹500 crores (approx) via initial public offer with a face value of ₹10 per equity share.
Tatva Chintan Pharma IPO is going to hit the market on 16 July 2021 and closes on 20 July 2021. Tatva Chintan Pharma IPO open on Friday fixed a price band of Rs1073-1083 a share for its Rs 500 crore (approx) IPO. The face value of equity shares of Tatva Chintan Pharma IPO is ₹10. Tatva Chintan Pharma company to raise ₹450 via initial public offer that comprises ₹225 crores of fresh issue and ₹225 crores of an offer for sale. Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure-directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India. Check out Tatva Chintan Pharma IPO details.
Tatva Chintan Pharma IPO Date & Price Band:
|IPO Opening Date||Jul 16, 2021|
|IPO Closing Date||Jul 20, 2021|
|Issue Type||Book Built Issue IPO|
|Face Value||₹10 per equity share|
|IPO Price||₹1073 to ₹1083 per equity share|
|Market Lot||13 Shares|
|Min Order Quantity||13 Share|
|Listing At||BSE, NSE|
|Issue Size||[.] Eq Shares of ₹10
(aggregating up to ₹500 Cr)
|Fresh Issue||[.] Eq Shares of ₹10
(aggregating up to ₹225 Cr)
|Offer for Sale||[.] Eq Shares of ₹10
(aggregating up to ₹275 Cr)
Tatva Chintan Pharma IPO Tentative Timetable
The Tatva Chintan Pharma IPO open date is 16 Jul 2021, and the close date is 20 Jul 2021. The issue may list on.
|IPO Open Date||Jul 16, 2021|
|IPO Close Date||Jul 20, 2021|
|Basis of Allotment Date||Jul 26, 2021|
|Initiation of Refunds||Jul 27, 2021|
|Credit of Shares to Demat Account||Jul 28, 2021|
|IPO Listing Date||Jul 29, 2021|
Tatva Chintan Pharma IPO Market Lot:
The Tatva Chintan Pharma IPO minimum market lot is 13 shares with ₹14,079 application amount. The retail investors can apply up to 14 lots with 182 shares or ₹1,97,106 amount.
|Minimum Lot Size:||Minimum 13 Shares|
|Maximum Lot Size:||Maximum 182 Shares|
Tatva Chintan Pharma Company Financial:
|Particulars||For the year/period ended (₹ in million)|
|Profit After Tax||2,468.97||3,130.98||1,955.92|
- Tatva Chintan Pharma IPO GMP (Grey Market Premium)
- Tatva Chintan Pharma IPO Subscription Status
- Tatva Chintan Pharma IPO Allotment Status
Tatva Chintan Pharma IPO Form:
How to apply the Tatva Chintan Pharma IPO? You can apply for Tatva Chintan Pharma IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Tatva Chintan Pharma IPO in the Invest section. The other option you can apply to Tatva Chintan Pharma IPO via IPO forms download via NSE and BSE. Check out the Tatva Chintan Pharma IPO forms – click NSE Forms & BSE Forms blank IPO forms download, fill, and submit in your bank or with your broker.
Tatva Chintan Pharma IPO Subscription Numbers
|Category||Day 1||Day 2||Day 3|
About Tatva Chintan Pharma
Tatva Chintan Pharma is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure-directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for supercapacitor batteries and pharmaceutical and agrochemical intermediates, and other specialty chemicals (“PASC”). Our Company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second-largest position globally. (Source: F&S Report) In addition, our Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. (Source: F&S Report) As a manufacturer of specialty chemicals, Tatva Chintan Pharma focuses on the application of our products which form a key ingredient to our customers’ manufacturing and industrial processes. For instance, our SDA and PTC products have various applications in green chemistry, which is pertinent considering the growing focus on green and sustainable technologies. They continuously strive to improve our processes and infrastructure to help reduce our impact on the environment and have accordingly, undertaken various ‘green’ chemistry processes such as electrolysis. Considering the wide application of our products, they serve customers across various industries, including the automotive, petroleum, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. Apart from our customers in India, Tatva Chintan Pharma also exports our products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK.
Tatva Chintan Pharma Company is promoted by Chintan Shah, Ajay Patel, and Shekhar Somani, who each has over 24 years in the specialty chemicals manufacturing industry and have established strong business relationships with domestic as well as overseas customers. In addition, they are led by a well–qualified and experienced management team, which we believe has demonstrated its ability to manage and grow our operations and has substantial experience in the sectors in which we operate. They believe that the knowledge and experience of our management team provide us with a significant competitive advantage as we seek to grow our business.
Tatva Chintan Pharma IPO Prospectus
Tatva Chintan Pharma Company Promoters:
- Ajaykumar Mansukhlal Patel
- Chintan Nitinkumar Shah
- Snehkar Rasiklal Somani
Tatva Chintan Pharma IPO Registrar:
Tatva Chintan Pharma IPO Lead Managers:
- ICICI Securities Ltd
- JM Financial Consultants Private Limited
Tatva Chintan Pharma Company Address:
Tatva Chintan Pharma IPO FAQs
What is Tatva Chintan Pharma IPO?
Tatva Chintan Pharma IPO is a main-board IPO. They are going to raise ₹500 Crores via IPO. The issue is priced at ₹1073 to ₹1083 per equity share. The IPO to be listed on BSE & NSE.
When Tatva Chintan Pharma IPO will open?
The Tatva Chintan Pharma IPO is to open on 16 July 2021 for QIB, NII, and Retail Investors.
What is Tatva Chintan Pharma IPO Investors Portion?
The investors’ portion for Tatva Chintan Pharma IPO is QIB 50%, NII 15%, and Retail 35%.
How to Apply the Tatva Chintan Pharma IPO?
You can apply for Tatva Chintan Pharma IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
How to Apply the Tatva Chintan Pharma IPO through Zerodha?
Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Tatva Chintan Pharma”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
What is Tatva Chintan Pharma IPO Size?
Tatva Chintan Pharma IPO size is ₹500 crores (Approx).
What is Tatva Chintan Pharma IPO Price Band?
Tatva Chintan Pharma IPO Price Band is ₹1073 to ₹1083.
What is Tatva Chintan Pharma IPO Minimum and Maximum Lot Size?
The minimum bid is 13 Shares with ₹14,079 amount while the maximum bid is 182 shares with ₹1,97,106.
What is Tatva Chintan Pharma IPO Allotment Date?
Tatva Chintan Pharma IPO allotment date is 26 July 2021.
What is Tatva Chintan Pharma IPO Listing Date?
Tatva Chintan Pharma IPO listing date is 29 July 2021. The IPO to list on BSE and NSE.